Clear 10°. Wind Chill: -6°. Wind: SW 6 mph.
Loading advertisement…
Trending: ‘Severe’ geomagnetic storm could make northern lights visible in southern US
HomeNewsNationalHealth ( Page 62)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Pritzker watching redistricting debate as GOP grapples with filibuster

(The Center Square) - In the aftermath of Tuesday's elections in other parts of the country, Illinois Gov. J.B. Pritzker is staying tuned to how Illinois could impact the ongoing debate over redistricting. ...
by

BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut

(Reuters) -BillionToOne was valued at $4.4 billion on Thursday, after the molecular diagnostics firm's shares jumped 66.67% in their Nasdaq debut, becoming the latest company to tap U.S. bourses amid a government shutdown. IPOs have made a striking comeback as AI exuberance and falling ...
by

Trump unveils deal to expand coverage and lower costs on obesity drugs

WASHINGTON (AP) - President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 ...
by

There are more than 100 autoimmune diseases, and they mostly strike women. Here’s what to know

Our immune system has a dark side: It's supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. What are called autoimmune diseases can affect just about every part of the body - and ...
by

Novo Nordisk expects global sales to decline by low single digits in 2026

(Reuters) -Novo Nordisk expects global sales to decline by low-single-digit percentage in 2026 after the drugmaker unveiled a deal on Thursday to slash prices of popular GLP-1 weight‑loss drugs for U.S. government-backed insurance programs and cash payers. (Reporting by Sriparna Roy in Bengaluru; Editing ...
by

Factbox-What is Metsera, the target in Pfizer’s and Novo Nordisk’s bidding war?

(Reuters) -Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment their pipeline in the booming weight-loss drug market. WHAT IS METSERA? Metsera is a New York-based clinical-stage biotech firm focused on developing treatments ...
Loading advertisement…
by

Trump unveils deal to expand coverage and lower costs on obesity drugs

WASHINGTON (AP) - President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 ...
by

Eli Lilly’s next generation weight loss drug shows promise, early trial results suggest

(NEW YORK) -- Eli Lilly's next generation of weight loss drugs appear to show promise, possibly leading to even faster weight loss and added health benefits, early trial results suggest.The pharmaceutical company presented the results for its newer drug at the annual ObesityWeek conference ...
by

Illinois quick hits: DHS ordered to address ICE facility conditions; Garcia explains retirement decision

DHS ordered to address ICE facility conditions A U.S. District Court judge in Chicago has issued a temporary restraining order directing Homeland Security Secretary Kristi Noem and federal immigration ...
by

Novavax raises annual revenue forecast on strength of vaccine deals

(Reuters) -Novavax raised its annual revenue forecast for the third time this year on Thursday, banking on milestone payments from vaccine supply and licensing deals such as with Japan's Takeda Pharmaceuticals. The upbeat outlook comes as the Gaithersburg, Maryland-based biotech faces persistent investor pressure over ...
by

Viagra-maker Viatris beats quarterly estimates on strong demand for branded drugs

(Reuters) -Drugmaker Viatris beat third-quarter estimates for profit and revenue on Thursday, driven by strong demand for its branded drugs in China and emerging markets. The company also raised its 2025 forecasts, which financial chief Doretta Mistras said was primarily based on foreign exchange benefits ...
by

Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle

By Sabrina Valle and Maggie Fick NEW YORK/LONDON (Reuters) -A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker Novo Nordisk locked in a $10 billion battle with U.S. rival Pfizer to win Metsera's obesity drug assets. Reuters reported ...
First Previous585960616263646566Next Last